- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 19.05. | Ionis chalks up phase 3 trial win as it works to grow the reach of Tryngolza | ||
| 19.05. | Former President Joe Biden diagnosed with 'aggressive' prostate cancer | ||
| 19.05. | Regeneron's $256M bid wins 23andMe bankruptcy auction | ||
| 19.05. | Amid US investment push, Lilly eyes Houston as potential home for $5.9B API plant | ||
| 19.05. | After FDA holdup, Novavax secures full approval for protein-based COVID vaccine | ||
| 16.05. | Weighing approval bids from J&J, Pfizer and Roche, FDA scrutinizes data ahead of adcomm | ||
| 16.05. | HHS, DARPA link up with Rutgers, Cost Plus Drugs and others in initiative to rethink US drug production | ||
| 16.05. | After 19 months, FDA lifts clinical hold on vaginal yeast infection drug Brexafemme | ||
| 16.05. | With marketing chief's departure, Omnicom Health loses another exec ahead of Interpublic merger | ||
| 16.05. | WuXi Biologics slims down again, handing off German plant to CDMO Terumo for $167M | ||
| 16.05. | Incyte's Zynyz secures approvals in anal cancer 4 years after FDA rejection | ||
| 16.05. | Novo to part ways with longtime CEO Lars Fruergaard Joergensen, citing weight of market pressures | ||
| 15.05. | Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit | ||
| 15.05. | GSK sponsors Lifetime movie for meningitis B vaccine awareness, with help from 'Buffy' stars | ||
| 15.05. | Merck KGaA cites Trump tariffs, funding cuts as it scales back 2025 contracting forecast | ||
| 15.05. | Novartis, Sarepta tipped to drive genomic therapy sales toward $90B | ||
| 15.05. | Riding its Peloton buyout, Merck rolls to third FDA nod for potential blockbuster Welireg | ||
| 15.05. | Merck's Keytruda finds a path in ovarian cancer with phase 3 win in certain patients | ||
| 14.05. | AbbVie advances solid tumor agenda with FDA nod for lung cancer ADC Emrelis | ||
| 14.05. | Sanofi hops on the US investment bandwagon with $20B commitment through 2030 | ||
| 14.05. | Genentech pays tribute to moms of children with hemophilia A in Hemlibra short film | ||
| 14.05. | Roche to reconsider US investment projects if Trump follows through on pricing order | ||
| 14.05. | Apellis' weak quarter for Syfovre signals uphill climb for geographic atrophy med: analyst | ||
| 14.05. | AbbVie plant workers in Ireland threaten to strike over pay dispute: reports | ||
| 14.05. | Bluebird bio investor reluctance pays off as Carlyle, SK improve buyout offer by 67% |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .